Virtual Medicinal Product (VMP) - Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler

Navigation

Name Details

Name Start Date End Date
Name Current Name Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Start Date 10-01-2022 End Date
Abbreviated Name Abbreviated Name Fluticasone propionate 202microg/Salmeterol 12.75microg/dose Start Date 10-01-2022

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
dose
Unit Dose UOM
dose

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Inhalation
Form
Inhalation powder
Ontology Form/Route
powderinhalation.inhalation
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
R03AK06
BNF Codes
  • BNF code 03020000
SNOMED Codes
Code Start Date End Date
40455811000001109 10-01-2022

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Fluticasone propionate Based on Ingredient Substance 202 microgram 1 dose
Salmeterol xinafoate Based on Base Substance Salmeterol 12.75 microgram 1 dose

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
60 dose